Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Tekla Healthcare Investors

+ Add to Watchlist

XHQHX:US

34.72 USD 0.63 1.78%

As of 20:00:00 ET on 05/22/2015.

Snapshot for Tekla Healthcare Investors (XHQHX)

Year To Date: +14.38% 3-Month: +6.07% 3-Year: +36.53% 52-Week Range: 26.57 - 35.67
1-Month: +0.11% 1-Year: +40.96% 5-Year: +29.97% Beta vs BTK: 0.82

Mutual Fund Chart for XHQHX

No chart data available.
  • XHQHX:US 34.72
  • 1M
  • 1Y
Interactive XHQHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XHQHX

Tekla Healthcare Investors Fund is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.

Inception Date: 04-22-1987 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD "DAN"
Web Site: www.teklacap.com

Fundamentals for XHQHX

NAV (on 2015-05-22) 34.72
Assets (M) (on 2015-05-21) 1,289.76
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for XHQHX

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-05-22) 0.68
Dividend Yield (ttm) 7.09

Fees & Expenses for XHQHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.95
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.13

Top Fund Holdings for XHQHX

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 1,039,942 78,151,641 10.619%
Celgene Corp 706,182 59,658,255 8.106%
Regeneron Pharmaceuticals Inc 178,740 49,196,398 6.685%
Biogen Inc 132,195 36,981,551 5.025%
Alexion Pharmaceuticals Inc 259,405 34,516,429 4.690%
Amgen Inc 286,769 32,737,549 4.448%
Actavis plc 158,892 26,693,856 3.627%
Vertex Pharmaceuticals Inc 346,735 25,762,411 3.501%
Perrigo Co PLC 154,896 23,770,340 3.230%
iShares Nasdaq Biotechnology E 97,826 22,212,372 3.018%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil